Upstream Bio, Inc. UPB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s total current liabilities?
- Upstream Bio, Inc. (UPB) reported total current liabilities of $13.67M in Q1 2026.
- How has Upstream Bio, Inc.'s total current liabilities changed year-over-year?
- Upstream Bio, Inc.'s total current liabilities increased by 42.9% year-over-year, from $9.57M to $13.67M.
- What is the long-term trend for Upstream Bio, Inc.'s total current liabilities?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s total current liabilities has grown at a 43.7% compound annual growth rate (CAGR), from $6.52M to $13.45M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.